Blog

New Studies EpicentRx Beta-Prime: A Phase I, First in Human, Study to Evaluate the Safety and Tolerability of AdAPT-001 in Subjects with Refractory Solid Tumors (NCT04673942) Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade...

Meet Sheena Reddy: A woman honors her mother’s fight against glioblastoma cancer while helping others.

Listen to our conversation with Dr. Kesari to find out what GBM treatments make him believe that big breakthroughs are on the horizon for treating this tricky, and tragic, disease.

Technology apps give you power in cancer care In a terrible accident, astronaut Steve Austin was severely injured and rushed to a top-secret high-tech facility. In a government-sanctioned surgery, scientists and doctors worked around the clock using experimental technology to install a bionic arm, eye,...

SIGNIFICANCE Glioblastoma (GBM) is the most common and lethal primary malignant brain tumor in adults. Despite the advances in understanding the molecular mechanism underlying GBM tumorigenesis, most of the current targeted therapies are still ineffective and temozolomide (TMZ) has remained the cornerstone of GBM treatment. Treatment...

An excellent team of outstanding neurosurgeons at Pacific Neuroscience Institute’s Brain Tumor Center has reported on 129 minimally invasive supraorbital (SO) surgeries in a recent paper; the highly encouraging results of a retrospective study are discussed. Minimally Invasive Surgery for Removal of Brain and Skull...

Our immune systems hold the power—the power, that is, to treat cancer. Composed of various types of cells, tissues, and organs, the immune system serves as more than the body’s main defense against foreign invaders such as bacteria and viruses. It also recognizes cancer cells...

Although our medical community continues to strain under the burden of COVID-19, there has been hope, determination and progress. Neurological diseases do not stop and neither have we at Pacific Neuroscience Institute.

This article was published on U.S News and World report, December 11, 2020 For loved ones left behind during the pandemic, suffering may endure for years. AS I WRITE THIS, COVID-19 has taken the lives of nearly 300,000 Americans. Each death leaves behind a circle of...

New Studies Blue Earth Diagnostics FLC-219: (PDF): An Open-label, Single-arm, Single-dose, Prospective, Multicenter Phase 2b Study to Establish Image Interpretation Criteria for 18F-Fluciclovine Positron Emission Tomography (PET) in Detecting Recurrent Brain Metastases After Radiation Therapy (PURSUE) (NCT04410367) Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A...